Jacobs Levy Equity Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-83,360
| Closed | -$150K | – | 1070 |
|
|
2022
Q3 | $150K | Buy |
+83,360
| New | +$150K | ﹤0.01% | 948 |
|
|
2022
Q1 | – | Sell |
-204,290
| Closed | -$952K | – | 1111 |
|
|
2021
Q4 | $952K | Buy |
+204,290
| New | +$952K | 0.01% | 745 |
|
|
2020
Q4 | – | Sell |
-35,768
| Closed | -$727K | – | 1116 |
|
|
2020
Q3 | $727K | Sell |
35,768
-6,105
| -15% | -$124K | 0.01% | 719 |
|
|
2020
Q2 | $643K | Buy |
+41,873
| New | +$643K | 0.01% | 746 |
|